Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
214.00
271.00
366.00
351.00
396.00
384.98
-63.33
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
214.00
271.00
366.00
351.00
396.00
384.98
-63.33
Raw Material Cost
105.00
111.00
171.00
153.00
133.00
129.05
166.17
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
49.00
47.00
87.70
96.60
136.10
77.46
128.14
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
124.00
143.00
140.00
154.00
191.00
183.23
141.43
Selling and Distribution Expenses
213.00
177.00
58.00
69.00
484.00
131.62
162.87
Other Expenses
-8.90
3.40
-16.37
30.54
-10.41
-21.03
-10.95
Total Expenditure (Excl Depreciation)
402.00
512.00
293.00
778.00
840.00
311.02
489.10
Operating Profit (PBDIT) excl Other Income
-188
-241
73
-427
-444
74
-552.4
Other Income
-9.00
2.00
9.00
2.00
5.00
-253.16
67.19
Operating Profit (PBDIT)
-154.00
-218.00
112.00
-357.00
-376.00
-122.29
-287.19
Interest
124.00
143.00
140.00
154.00
191.00
183.23
141.43
Exceptional Items
-612.00
-116.00
54.00
98.00
19.00
44.11
-0.95
Gross Profit (PBDT)
66.00
139.00
143.00
130.00
200.00
199.04
-286.12
Depreciation
43.00
21.00
52.00
68.00
63.00
56.90
56.62
Profit Before Tax
-933.00
-498.00
-4.00
-481.00
-611.00
-318.32
-486.19
Tax
-10.00
-14.00
-5.00
41.00
25.00
10.52
-63.94
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-895.00
-462.00
-264.00
-370.00
-376.00
-283.72
-380.87
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-895.00
-462.00
-264.00
-370.00
-376.00
-283.72
-380.87
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-122.00
-347.00
56.00
-226.00
28.00
5.98
-35.77
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-1,017.00
-809.00
-208.00
-596.00
-348.00
-277.74
-416.64
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.0
Reserves
12.00
921.00
1,549.00
2,002.00
2,382.00
2,490.18
2,630.80
Earnings per share (EPS)
-0.12
-0.06
-0.04
-0.06
-0.06
-0.05
-0.08
Diluted Earnings per share
-0.12
-0.06
-0.04
-0.06
-0.06
-0.05
-0.08
Operating Profit Margin (Excl OI)
-87.85%
-88.93%
19.95%
-121.65%
-112.12%
19.21%
0.0%
Gross Profit Margin
-415.89%
-176.01%
13.11%
-117.66%
-138.38%
-67.9%
678.35%
PAT Margin
-418.22%
-170.48%
-72.13%
-105.41%
-94.95%
-73.7%
0.0%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is -21.03% vs -25.96% in Mar 2024
Consolidate Net Profit
YoY Growth in year ended Mar 2025 is -25.71% vs -288.94% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 34.09% vs -313.59% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -13.29% vs 2.14% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has improved from Mar 2024
Compare Annual Results Of Aceso Life Science Group Ltd. With
Figures in Million
Consolidate Annual Results
Change(HKD)
Change(%)
Net Sales
214.00
159.97
54.03
33.78%
Other Operating Income
0.00
0.00
0.00
Total Operating income
214.00
159.97
54.03
33.78%
Raw Material Cost
105.00
89.50
15.50
17.32%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
49.00
63.54
-14.54
-22.88%
Power Cost
0
0
0.00
Manufacturing Expenses
124.00
10.11
113.89
1,126.51%
Selling and Distribution Expenses
213.00
97.28
115.72
118.96%
Other Expenses
-8.90
-5.27
-3.63
-68.88%
Total Expenditure (Excl Depreciation)
402.00
207.69
194.31
93.56%
Operating Profit (PBDIT) excl Other Income
-188.00
-47.73
-140.27
-293.88%
Other Income
-9.00
4.09
-13.09
-320.05%
Operating Profit (PBDIT)
-154.00
-14.16
-139.84
-987.57%
Interest
124.00
10.11
113.89
1,126.51%
Exceptional Items
-612.00
-34.63
-577.37
-1,667.25%
Gross Profit (PBDT)
66.00
70.47
-4.47
-6.34%
Depreciation
43.00
29.48
13.52
45.86%
Profit Before Tax
-933.00
-88.37
-844.63
-955.79%
Tax
-10.00
-0.33
-9.67
-2,930.30%
Provisions and contingencies
0
0
0.00
Profit After Tax
-895.00
-88.11
-806.89
-915.78%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-895.00
-88.11
-806.89
-915.78%
Share in Profit of Associates
0
0
0.00
Minority Interest
-122.00
0.07
-122.07
-174,385.71%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-1,017.00
-88.04
-928.96
-1,055.16%
Equity Capital
0
0
0.00
Face Value
0.01
0.04
0.00
Reserves
12.00
-83.20
95.20
114.42%
Earnings per share (EPS)
-0.12
-0.03
-0.09
-300.00%
Diluted Earnings per share
-0.12
-0.03
-0.09
-300.00%
Operating Profit Margin (Excl OI)
-87.85%
-29.84%
0.00
-58.01%
Gross Profit Margin
-415.89%
-36.81%
0.00
-379.08%
PAT Margin
-418.22%
-55.08%
0.00
-363.14%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 21.40 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is -21.03% vs -25.96% in Mar 2024
Annual - Consolidate Net Profit
Consolidate Net Profit -101.70 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is -25.71% vs -288.94% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) -14.50 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 34.09% vs -313.59% in Mar 2024
Annual - Interest
Interest 12.40 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is -13.29% vs 2.14% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -87.85%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has improved from Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
